Key result
Elevated NT-proBNP levels were significantly more common in older patients with resistant hypertension compared to younger patients (64.7% vs 8.8%, p<0.001), suggesting a link to HFPEF.
Why the study?
Is resistant hypertension in the elderly associated with elevated NT-proBNP and larger left atrial diameter, suggesting a clinical manifestation of HFpEF?
Observational (n=68)
No
Is resistant hypertension in the elderly associated with elevated NT-proBNP and larger left atrial diameter, suggesting a clinical manifestation of HFpEF?
Resistant hypertension in the elderly is frequently associated with elevated NT-proBNP and enlarged left atrium, suggesting it may be a clinical presentation of HFpEF.
Answers are grounded in this paper and cite their sources.
May suggest HFpEF evaluation in elderly resistant hypertension; hypothesis-generating and requires prospective validation.
Background: Resistant hypertension (RHT) is defined as high blood pressure despite three antihypertensive medications one being a diuretic. RHT is a common clinical problem and as a subgroup has not been studied widely. The present study has investigated patient demographics and if the RHT might be a clinical presentation of heart failure with preserved ejection fraction (HFPEF) in elderly.Method: The outpatient data between January and June 2015 of Izmir Kemalpasa State hospital’s hypertension specialty clinic has been reviewed retrospectively. The patients with pseudo-RHT are excluded. Among 957 patients, 68 patients have been identified as true RHT with a left ventricle ejection fraction ≥50%. HFPEF is defined according to the latest guideline. Instead of a common cut-off level for NT-proBNP, age and gender-related cut-off levels have been used.Results: The mean age was 63.24 ± 12.05 years. Among 68 patients, 49 were female. While only 3 patients in younger group (8.8%) had elevated levels of NT-proBNP, 22 of older RHT patients (64.7%) had high levels. NT-proBNP levels were disproportionally high in elderly (p < 0.001) and high levels in RHT patients were related to a larger left atrial diameter (p < 0.001).Conclusion: The underlying mechanism might be different in RHT according to age. Hypervolemia might be the key factor in older RHT patients but not in younger patients. The current study suggests RHT in elderly can be a clinical presentation of HFPEF, and they should be investigated and treated accordingly. Because of single-center results and limited patients, further studies are needed.
No takes yet. Share an insight, caveat, or question.
Türkoğlu et al. (2018) conducted an observational in Resistant hypertension (n=68). Elevated NT-proBNP levels were significantly more common in older patients with resistant hypertension compared to younger patients (64.7% vs 8.8%, p<0.001), suggesting a link to HFPEF.
Synapse has enriched 10 related papers. Consider them for comparative context: